SANGRIX INC. (SGRX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for Q2 FY2026, filed Jun 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SGRX SEC filings page.
SANGRIX INC. (SGRX) reported $39K in revenue for fiscal year 2025, down 98.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
SANGRIX INC. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
SANGRIX INC. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
SANGRIX INC. reported a net loss of $4.4M while operations used $2.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.
SANGRIX INC. reported an operating loss of $3.0M against $455K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q2 2026.
Cash & Balance Sheet
SANGRIX INC. held $485K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
SGRX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
SGRX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-K | Q4'2510-K | Q2'2510-Q | Q4'2410-K | Q2'2410-Q | Q4'2310-K | Q4'2210-K | Q4'2110-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.9M+220.1% | $3.5M-47.1% | $4.0M-70.0% | $6.7M-49.9% | $13.5M | $13.3M-61.8% | $35.0M-14.5% | $40.9M-35.5% |
| Current Assets | $12.7M+215.1% | $3.5M-47.1% | $4.0M-55.8% | $6.7M+87.1% | $9.1M | $3.6M-85.1% | $23.9M-26.4% | $32.5M-35.3% |
| Cash & Equivalents | $485K | $56K-96.1% | N/A | $1.4M+8558.4% | $6.9M | $16K-8.6% | $18K+816.4% | $2K-99.8% |
| Short-Term Investments | $0 | $0 | N/A | $0 | $0 | $0 | $0 | $0 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $229K |
| Accounts Receivable | $0 | N/A | $0 | $117K | $0 | $0 | $0-100.0% | $11.1M+13.3% |
| Long-Term Investments | $0 | $0 | N/A | $0-100.0% | $2.4M | $2.4M-20.3% | $3.0M | $0 |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% |
| Total Liabilities | $14.7M+148.1% | $372K-93.6% | $5.9M+31.5% | $5.8M+87.8% | $4.5M | $3.1M+925.0% | $300K-99.3% | $42.5M+16.4% |
| Current Liabilities | $283K-85.7% | $372K-85.1% | $2.0M+21.0% | $2.5M-3.8% | $1.6M | $2.6M+762.9% | $300K-99.2% | $38.7M+18.2% |
| Non-Current Liabilities | $14.4M+264.9% | $0-100.0% | $4.0M+37.4% | $3.3M+575.3% | $2.9M | $486K | $0-100.0% | $3.8M+0.3% |
| Total Equity | -$1.1M+3.0% | $3.9M+134.6% | -$1.1M-112.6% | $1.7M-83.8% | $9.0M | $10.3M-70.4% | $34.7M+1175.7% | -$3.2M-113.5% |
Not reported in any period shown, so not listed: Long-Term Debt, Retained Earnings.
SGRX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
SGRX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Where SANGRIX INC. Ranks
Frequently Asked Questions
What is SANGRIX INC.'s annual revenue?
SANGRIX INC. (SGRX) reported $39K in total revenue for fiscal year 2025. This represents a -98.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is SANGRIX INC.'s revenue growing?
SANGRIX INC. (SGRX) revenue declined by 98.6% year-over-year, from $2.9M to $39K in fiscal year 2025.
Is SANGRIX INC. profitable?
No, SANGRIX INC. (SGRX) reported a net income of -$4.4M in fiscal year 2025.
What is SANGRIX INC.'s EBITDA?
SANGRIX INC. (SGRX) had EBITDA of -$3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is SANGRIX INC.'s gross margin?
SANGRIX INC. (SGRX) had a gross margin of 100.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is SANGRIX INC.'s return on equity (ROE)?
SANGRIX INC. (SGRX) has a return on equity of -112.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is SANGRIX INC.'s operating cash flow?
SANGRIX INC. (SGRX) recorded an outflow of $2.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are SANGRIX INC.'s total assets?
SANGRIX INC. (SGRX) had $3.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What is SANGRIX INC.'s current ratio?
SANGRIX INC. (SGRX) had a current ratio of 9.50 as of fiscal year 2025, which is generally considered healthy.
What is SANGRIX INC.'s debt-to-equity ratio?
SANGRIX INC. (SGRX) had a debt-to-equity ratio of 0.10 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SANGRIX INC.'s return on assets (ROA)?
SANGRIX INC. (SGRX) had a return on assets of -123.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is SANGRIX INC.'s P/E ratio?
SANGRIX INC. (SGRX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $1.4M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is SANGRIX INC.'s price-to-sales ratio?
SANGRIX INC. (SGRX) trades at 35.4x sales, its market capitalization divided by revenue of $39K revenue, FY2025. The market capitalization is $1.4M as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does SANGRIX INC.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, SANGRIX INC. (SGRX) held $56K in cash, cash equivalents and investments, and reported an operating cash outflow of $2.3M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is SANGRIX INC.'s Piotroski F-Score?
SANGRIX INC. (SGRX) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are SANGRIX INC.'s earnings high quality?
SANGRIX INC. (SGRX) reported a net loss of $4.4M while operations used $2.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can SANGRIX INC. cover its interest payments?
SANGRIX INC. (SGRX) reported an operating loss of $3.0M against $455K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.